Hohnloser, Stefan H.
,
Calkins, Hugh
Willems, Stephan
Verma, Atul
Schilling, Richard
Okumura, Ken
Nordaby, Matias
Kleine, Eva
Biss, Branislav
Gerstenfeld, Edward P.
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 24 October 2018
Accepted: 15 January 2019
First Online: 13 February 2019
Compliance with ethical standards
: The study was performed in accordance with the provisions of the Declaration of Helsinki and the International Conference on Harmonisation Good Clinical Practice Guidelines [CitationRef removed, CitationRef removed]. The study protocol and procedures were approved by relevant institutional review boards and ethics committees, and all patients provided written informed consent before entering the study.
: S.H. Hohnloser reports being a consultant, advisor, or speaker for Bayer HealthCare, Bristol-Myers Squibb, Boehringer Ingelheim, Boston Scientific, Cardiome, Forest RI, Gilead, Johnson & Johnson, Medtronic, Otsuka, Pfizer, Portola, Sanofi Aventis, Servier, St. Jude Medical, and Zoll. H. Calkins has received lecture honoraria from Boehringer Ingelheim and Medtronic, and is a consultant to Abbot Medical, AtriCure, and Medtronic. S. Willems has received honoraria as a consultant, advisor, or speaker from Abbott, Bayer HealthCare, Bristol-Myers Squibb, Boehringer Ingelheim, Boston Scientific, Johnson & Johnson, and Medtronic. A. Verma has received research grants from Bayer HealthCare, Boehringer Ingelheim, Daiichi Sankyo, Biotronik, and is a consultant to Biosense Webster and Medtronic. R. Schilling has received research grants from Biosense Webster, Boston Scientific, Medtronic, and St. Jude Medical, and received honoraria and travel sponsorship from Biosense Webster, Boehringer Ingelheim, Boston Scientific, Medtronic, and St. Jude Medical. K. Okumura has received honoraria from Bayer HealthCare, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, and Medtronic. M. Nordaby and E. Kleine are full-time employees of Boehringer Ingelheim International GmbH. B. Biss is a full-time employee of Boehringer Ingelheim RCV, Vienna, Austria. E.P. Gerstenfeld has received honoraria from Boehringer Ingelheim, a research grant and honoraria from Biosense Webster, and a research grant and honoraria from St. Jude Medical.